Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Examining Resources, Initiatives, and Regulatory Pathways to Advance Regenerative Medicine Manufacturing

Published

Author(s)

Joshua Hunsberger, Martha Lundberg, Julie Allickson, Claudia Zylberberg, Sarah Beachy, Carl Simon Jr.

Abstract

This perspective article is inspired by a workshop entitled "Cell and Tissue Manufacturing Innovation" that was held at the Tissue Engineering and Regenerative medicine Society (TERMIS). Five main concepts are discussed: 1) the US National Academies' Forum on Regenerative Medicine, 2) academic translational programs, 3) developing measurements for regenerative medicine, 4) developing standards for ancillary materials and 5) the global landscape for accelerating regenerative medicine manufacturing. Concepts are presented with current perspective and key insights on challenges, opportunities and next steps for cell and tissue manufacturing innovation.
Citation
Cytotherapy

Keywords

tissue engineering, regenerative medicine, documentary standards, biomanufacturing

Citation

Hunsberger, J. , Lundberg, M. , Allickson, J. , Zylberberg, C. , Beachy, S. and Simon Jr., C. (2019), Examining Resources, Initiatives, and Regulatory Pathways to Advance Regenerative Medicine Manufacturing, Cytotherapy, [online], https://doi.org/10.1007/s40778-019-00163-0 (Accessed June 17, 2024)

Issues

If you have any questions about this publication or are having problems accessing it, please contact reflib@nist.gov.

Created August 8, 2019, Updated January 24, 2023